Both in Diagnostics
Lantheus Holdings vs Myriad Genetics
Over the past year LNTH returned +74.1% and MYGN returned −21.0%; their daily moves had a correlation of 0.13.
LNTH +74.1% MYGN −21.0%Growth of $1, one year, split-adjusted
| Metric | LNTH | MYGN |
|---|---|---|
| Price | $100.46 | $6.35 |
| Market cap | $6.56B | $607.4M |
| Today | +0.14% | −4.80% |
| 1 month | +0.8% | +56.4% |
| 6 months | +17.5% | +32.3% |
| Year to date | +51.0% | +3.3% |
| 1 year | +79.8% | −19.7% |
| Revenue growth (YoY) | +2.7% | −10.5% |
| Gross margin | 62.3% | 66.6% |
| Net margin | 19.3% | −22.7% |
| P/E (TTM) | 23.8× | — |
| Price / sales | 4.2× | 0.8× |
| Net cash | $22.2M | -$5.5M |
| Dividend yield | — | — |
| Volatility (60d) | 3.9% | 82.9% |
| Short % of float | 5.7% | 10.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).